Table 1 Patient characteristics.
| EA group (n=6) | LA group (n=11) | P value | |
|---|---|---|---|
| Age | 71.3±9.9 | 65.2±11.5 | 0.43 |
| Sex (male/female) | 4/2 | 10/1 | 0.21 |
| Hypertension | 4 (66.7%) | 7 (63.6%) | 0.90 |
| Diabetes mellitus | 1 (16.7%) | 6 (54.5%) | 0.13 |
| Dyslipidemia | 0 (0%) | 4 (36.4%) | 0.09 |
| Coronary artery disease | 0 (0%) | 3 (27.3%) | 0.16 |
| Cerebrovascular disease | 1 (16.7%) | 1 (9.1%) | 0.64 |
| End-stage renal disease | 1 (16.7%) | 3 (27.3%) | 0.62 |
| Smoking | 4 (66.7%) | 9 (81.8%) | 0.48 |
| Steroid | 1 (16.7%) | 0 (0%) | 0.16 |
| Primary disease | AAA 2, ASO 3, Takayasu arteritis 1 | AAA 1, ASO 6, Buerger disease 1, Behcet disease 2, acute thromboembolism 1 |
EA: early antibiotic; LA: late antibiotic; AAA: abdominal aortic aneurysm; ASO: arteriosclerosis obliterans